Amir Pesyan (Co-Founder, Senior Principal Scientist) is a Professional Medicinal Chemist (York University, with Honours, 1996) with over twenty years of industrial biotech experience (in Canada, the U.S., and Europe) in the design and synthesis of various Active Pharmaceutical Ingredients (APIs). His work experience includes research positions at York University, Dalton Chemical Laboratories, Triangle Pharmaceuticals (Research Triangle Park), Icagen, and NPS Pharmaceuticals. His professional activities have included the synthesis and scale-up of various novel anti-viral (anti-HIV) and CNS-active drug product candidates: analgesics for neuropathic pain, as well as anti-anxiety, anticonvulsant, and neuroprotective agents. Pesyan is a named Inventor on a number of U.S. and international pharmaceutical patents and patent applications.
Michael A. Cederstrom, J.D. (General Counsel and Corporate Secretary) graduated from University of Utah with honors with a degree in finance. Mr. Cederstrom continued his studies at the University of Utah towards a master's degree in business administration. Prior to completing the MBA degree he transferred to Southwestern University and graduated with honors, obtaining a Juris Doctor degree. Mr. Cederstrom practiced law with Dexter & Dexter and currently specializes in Business Law, including initial organization of business entities, maintenance of the entity, employment issues and business tax issues. Mr. Cederstrom also practices in the areas of estate planning, probate and tax issues, banking law and elder law.